Grifols, S.A. - American Depositary Shares (GRFS) analyst actions
Rating and price-target actions on GRFS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the GRFS overview →
1 measured GRFS analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors | Press release | +1.15% | +2.17% |
Keep exploring
More GRFS: earnings → · SEC filings → · GRFS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Repligen Corporation (RGEN) | 301 | +0.15% | 55% |
| EIDOS THERAPEUTICS (EIDX) | 300 | +0.01% | 51% |
| Sangamo Therapeutics, Inc. (SGMO) | 300 | -0.55% | 38% |
| Merit Medical Systems, Inc. (MMSI) | 299 | -0.03% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.